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motif present in Fas/APO1 (CD95), a structurally-related r - 
Abstract A novel protein that binds specifically to the intraeel- ceptor that also signals for cell-death. Also the death domain 
lular domain of the p55 tumor necrosis factor (TNF) receptor was of Fas/APO1 self-associates and binds to an analogous e- 
cloned by two-hybrid screening of a HeLa cell eDNA library. 
Data bank searches revealed high sequence similarity of the pro- quence in a recently cloned cytoplasmic protein, MORT1, 
tein (55.11) to yeast, nematode and plant proteins, whose func- which appears to participate in induction of cell death by Fas/ 
tions are yet unknown. Significant similarity was also found be- APO1 [8,9]. Besides inducing cell death, the death domain of 
tween 55.11 and SEN3, the yeast equivalent of the pl12 subunit p55-R contributes to the induction of noncytocidal TNF ef- 
of the 26S proteasome. Deletion analysis showed that the protein fects, including anti-viral state and activation of the acid sphin- 
binds to the p55 receptor upstream to the region involved in gomyelinase [6,10]. However, signaling for some TNF effects 
induction of cell death, involves regions of p55-R other than its death domain. For 
example, the TNF-induced activation of the neutral sphin- 
Key words." Death domain; Receptor; Proteasome; Signaling; gomyelinase involves a region located upstream to the death 
Tumor necrosis factor; Two-hybrid system domain, and the induction of nitric oxide synthase involves 
both the death domain and a region located upstream to it 
[6,10]. Besides being involved in signaling, the membrane prox- 
1. Introduction imal part of p55-IC participates in the regulation of uptake of 
the receptor [11]. We report here the cloning of a protein that 
binds to the intracellular domain of the p55-R (p55-IC) at a 
Triggering of the two TNF receptors, the p55 receptor (p55-R; 
CD120a) and the p75 receptor (p75-R; CD120b), initiates region upstream to its death domain. 
a wide range of effects, including modulation of differentiation 
2. Materials and methods 
patterns, activation of various immune mechanisms, induction 
of cell death, and stimulation ofcell growth [1-3]. As with other 2.1. Cloning of the eDNA of 55.11 
receptors, these varied activities and their coordinated induc- A partial eDNA of 55.11 (nts 925-2863, which encode for amino 
tion are likely to be effected by heterogeneity of functional acids 309 900; see Fig. 4) was cloned by a two hybrid screen [12] of a 
motifs in the TNF receptors and of effector proteins with which Gal4 activation domain-tagged HeLa cell cDNA library (Clontech, 
Palo Alto, CA, USA), as previously described [9]. The rest of the 55.11 
the receptors interact. Currently, the majority of information cDNA (nts 1-924, which encode for amino acids 1 308) was cloned by 
available on the mechanisms of action of the TNF receptors PCR from a human fetal iver cDNA library. The nucleotide sequence 
concerns the C-terminal regions in the receptors' intracellular of 55.11 was determined in both directions by the dideoxy chain termi- 
domains. In the p75-R, a region of about 78 amino acids in the nation method. 
C terminus of the receptor is involved in the enhancement of 2.2. Two hybrid ~-galactosidase expression tests 
T cell growth and NFIcB activation by TNF. Two proteins that fl-galactosidase expression tests were performed as previously de- 
bind to this C terminal region (TRAF1 and TRAF2) probably scribed [8], except hat in part of the tests, the pVP16 vector, which 
take part in the involved signaling [4]. Studies on the mecha- contains the activation domain of VPI6, was used instead of pGAD- 
nisms of action of p55-R have focused on a conserved sequence GH, the Gal4 activation domain vector. Numbering of residues in the 
proteins encoded by the cDNA inserts are as in the Swiss-Prot data 
motif of about 80 amino acids at its C terminus, which signals bank. Deletion mutants were produced by PCR, and point mutants by 
for cell death, and therefore, has been called the 'death domain' oligonucleotide-directed mutagenesis [13]. 
[5,6]. This motif, which is also present in some other proteins 
[7,8], can self-associate and bind to analogous sequences. The 2.3. Northern analysis 
Total RNA was isolated using TRI REAGENT (Molecular Research 
death domain of p55-R binds to itself and to a death domain Center, Inc., Cincinnati, OH), denatured in formaldehyde/formamide 
buffer, electrophoresed through an agarose/formaldehyde gel, and blot- 
*Corresponding author. Fax: (972) (8) 343165. ted to a GeneScreen Plus membrane (Dupont, Wilmington, DE, USA) 
E mail: LVWALACH@WEIZMANN.WEIZMANN.AC.IL in 10 × SSPE buffer, using standard techniques. The blots were hybrid- 
ized with the cDNA of 55.11 (nts 925 2,863), radiolabeled with the 
The nucleotide sequence of55.11 will appear in the GenBank/EMBL random-prime kit (Boehringer Mannheim Biochemica, Mannheim, 
Data Bank under Accession Number X86446. Germany), and washed stringently. Autoradiography was performed 
for l week. 
Abbreviations." GST, glutathione S-transferase; Fas-IC, intracellular 
domain of Fas/APO1; FLAG-55.11, the region extending between res- 2.4. Expression of" 55.11 cDNA in HeLa cells and binding of the 55.11 
idues 309 and 900 in the 55.11 protein and which was N-linked to the protein to glutathione S-transferase fusion proteins ofp55-lC 
FLAG octapeptide; IC, intracellular domain; p55-R, the p55 receptor Glutathione S-transferase (GST) fusions with p55-IC (GST-p55IC) 
for TNF; p75-R, the p75 receptor for TNF; p55-IC, intracellular do- and with p55-IC truncated below amino acid 345 (GST-p55IC345) were 
main of the p55-R; TNF, tumor necrosis factor, produced and adsorbed to glutathione-agarose beads as previously 
0014-5793195l$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
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Fig. 1. Binding of the 55.11 protein to p55-IC, within transformed yeast. Binding of human p55-IC (residues 206426) and various deletion mutants 
to activation domain hybrids containing 55.11 was examined in transfected SFY526 yeast. Gal4 DNA binding domain constructs (pGBT9) and either 
Gal4 (pGAD-GH) or VP16 (pVP16) activation domain constructs were used. The binding was assessed by a two-hybrid fl-galactosidase expression 
filter assay. SNFI and SNF4 served as positive controls and the empty Gal4 and VP16 vectors as negative controls. +++ and ++ indicate the 
development of strong color within 20 and 60 min of initiation of the assay, respectively. - indicates no development of color within 24 h. Blanks 
indicate not tested. The 55.11 protein did not bind to lamin, cyclin D, and the intracellular domains of human Fas/APO 1 (residues 175-319), CD40 
(residues 216 277), and p75-R (residues 287461) (data not shown). 
described [9,14,15]. The cDNAs of 55.11 (nts 1 2863), of FLAG-55.1 l, which the death domain had been deleted (construct 206-328 
and of luciferase were expressed in HeLa cells. FLAG-55.11 is the in Fig. 1), more effectively than to nontruncated p55-IC. It also 
region extending between residues 309 and 900 in the 55.11 protein (the bound to an even further C terminally truncated construct 
partial cDNA of 55.11 (nts 925-2863), originally cloned by the two (construct 206-308) and to a construct from which both the 
hybrid screen), N-linked to the FLAG octapeptide (Eastman Kodak, 
New Haven, CT). Expression of the fusion proteins was accomplished death domain and a membrane proximal part were deleted 
using a tetracycline-controlled expression vector (HtTA-1) in a HeLa (construct 243-328). However, the 55.11 protein did not bind 
cell clone that expresses a tetracycline-controlled transactivator [9,16]. to a construct hat was N-terminally truncated own to amino 
Metabolic labeling of the expressed proteins with [35S] Met and [35S]Cys 
(Dupont, Wilmington, DE, and Amersham, Buckinghamshire, UK), 
lysis of the HeLa cells, immunoprecipitation, a d binding of the labeled ~¢~ ~,~ ..,~1,,~" o,QO y
proteins to the GST fusion proteins were performed as described before ,~No 
[8], except hat 0.5% rather than 0.1% Nonidet P-40 was present in the 
cell lysis buffer. The immunoprecipitations f 55.11 and FLAG-55.11 
were achieved using a rabbit antiserum (diluted 1 : 500) raised against 
a GST fusion protein containing the region of 55.11 that extends be- .q1--.--28S 
tween amino acids 309 and 900 and a mouse monoclonal antibody 
against he FLAG octapeptide (M2; Eastman Kodak; 5 pg/ml of cell 
lysate). 
3. Results and discussion .91 - - -18S  
Since the death domain of p55-IC tends to self-associate [9], 
two-hybrid screens [12] for proteins that bind to p55-IC yield Fig. 2. Northern analysis of the RNA from several cells lines, using the 
primarily the cDNA ofp55-IC itself. However, when screening 55.11 cDNA as a probe. The cell lines examined were HeLa, CEM, 
a HeLa cell library with p55-IC we isolated a cDNA clone Jurkat, and Hep G2 cells derived from human epithelioid carcinoma, 
an acute lymphoblastic T cell leukemia, an acute T cell leukemia, and 
(55.11) whose binding site to p55-IC appeared istinct from the a hepatocellular carcinoma, respectively. The 55.11 cDNA (nts 925- 
death domain. The protein bound to a truncated p55-IC from 2863) was used as a probe. Samples consisted of 10/.tg of RNA/lane. 
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Fig. 3. In vitro binding of the protein encoded for by 55.11 to GST fusion proteins containing portions of p55-IC. Binding of the full length 55.11 
protein (55.11-full) (A) and of FLAG-55.11 (amino acids 309-900 of 55.11, encoded by the initially cloned partial cDNA, fused at the N terminus 
with the FLAG octapeptide) (B). The cDNAs for the full-length 55.11, FLAG-55.11, and luciferase (control) were expressed in transfected HeLa 
cells and metabolically abeled with [355]Met and [355]Cys. The following proteins were fused with GST: full-length p55-IC (GST-p55-IC), p55-IC 
C-terminally truncated up to amino acid 345 (GST-p55-IC345), and the MORT1 protein (GST-MORT1). GST-MORT1 and GST alone served as 
controls. Lysates of the transfected cells were immunoprecipitated with antibodies against the 55.11 protein or the FLAG octapeptide. The proteins 
were analyzed by SDS-polyacrylamide gel electrophoresis (10% acrylamide), followed by autoradiography. 
acid 266 (Fig. 1). These findings indicate that the binding site p55-IC (Fig. 1). Thus, the structure(s) involved in this binding 
for 55.11 is located in the region that extends between residues appear to reside within the 55.11 molecule and not to involve 
243 and 308 of p55-IC and that the N terminus of this binding the site of fusion of 55.11 with the activation domain. However, 
site is between residues 243 and 266. binding of 55.11 to p55-IC was abolished by even limited trun- 
Transfer of the cDNA for 55.11 from the originally cloned cations of the 55.11 protein at either its C (construct 309-680) 
'prey' construct, which contained the Gal4 activation domain, or N terminus (construct 457-900. Residue 309 is the first 
to a prey construct containing the VP16 activation domain did residue in the protein encoded by the partial cDNA clone orig- 
not decrease the binding efficiency of the 55.11 protein to inally isolated in the two hybrid screen). The observed binding 
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appeared to be specific since 55.11 did not bind to other pro- that these proteins are as similar to 55.11 as the YHR027c 
reins, including three receptors of the TNF/NGF receptor fam- protein of yeast. The only one of these four proteins whose 
ily (p75-R, Fas/APO1 and CD40; data not shown), nature has been elucidated so far is the yeast SEN3, whose 
Northern analysis using the 55.11 cDNA as a probe (Fig. 2) homology to 55.11 is limited. SEN3 has been identified as the 
revealed, in several cell lines, a single hybridizing transcript of yeast equivalent of the p 112 subunit of an activator of the 20S 
about 3 kb, which is larger than the cDNA (2 kb). Using proteasome (the proteolytic core of the 26S proteasome [17,18]) 
oligonucleotide primers that correspond to the 55.11 sequence, (M. R. Culbertson and M. Hockstrasser, personal communica- 
we cloned by PCR a 5' extending sequence whose length was tion). 
about 1 kb. The sum of the length of this 5' extending sequence Conserved amino acid sequence motifs were not discerned 
with that of the originally cloned cDNA approximates the within the protein encoded for by 55.11, except for a repetitive 
length of the 55.11 transcript. The 3 kb cDNA that encom- 'KEKE'  sequence that extends between Lys m4 and Glu 632. Such 
passed both these portions was effectively expressed in trans- 'KEKE'  sequences, which are present in many proteins, includ- 
fected HeLa cells yielding a protein of about 84 kDa, which ing proteasomal subunits and chaperonins, may promote asso- 
suggests that the 3 kb cDNA contains a translational start site. ciation of protein complexes [19], A sequence AYAGS(x)sLL 
To ascertain that 55.11 can indeed bind to p55-IC and to appears twice in the 55.11 protein (at sites 479 and 590, see 
exclude involvement of yeast proteins in this binding, the in Fig. 4); no functional significance for this sequence has yet been 
vitro interaction of GST p55-IC fusion proteins, produced by described. 
bacteria, with the protein encoded by the 3 kb 55.11 cDNA Findings in this study suggest several possible routes that 
(55.11-full), produced by transfected HeLa cells, was examined, could be explored to elucidate the function served by the 55.11 
The protein encoded by 55.11 bound to fusion proteins that protein and how its binding to the p55-R contributes to TNF 
contained the full p55-IC (GST-p55IC) or a truncated p55-IC activity. The finding that the 55.11 protein is bound to a region 
that lacked most of the death domain (GST-p55IC345)(Fig. 3A). in the p55-R distinct from the death domain indicates that it 
The protein did not bind to GST alone or to GST fused affects noncytocidal TNF activiti(es). There are indications that 
to the MORT1 protein (control). Similarly, the HeLa cell-ex- the region to which the 55.11 protein binds contains equence 
pressed protein encoded by the initially cloned partial cDNA motifs involved in TNF induced expression of nitric oxide syn- 
of 55.11 in fusion with the FLAG octapeptide (FLAG-55.11) thase [6] and activation of neutral sphingomyelinase [10]. How- 
bound in vitro to GST-p55IC and GST-p55IC345, but not to ever, these motifs have not yet been fully defined. The region 
GST or GST-MORTI (Fig. 3B). is particularly rich in proline, serine, and threonine residues; yet 
Data bank searches revealed that parts of the sequence of the it does not contain the RPM1 and RPM2 proline-rich motifs, 
55.11 cDNA (Accession Numbers T03659, Z19559, and present in several other cytokine receptors [20]. Proline residues 
F09128) and its mouse homologue (Accession Numbers follow two serines and two threonines in the N terminal part 
X80422 and Z31147) have already been determined during ar- of the binding region of the 55.11 protein, making them poten- 
bitrary sequencing of cDNA libraries. A cDNA sequence (Ac- tial sites for phosphorylation byMAP kinase, CDC2, and other 
cession Number U18247) that encodes for a human protein of proline-dependent kinases [21], which may affect receptor bind- 
596 amino acids present in cultures of human hepatoma HCI0 ing by the 55.11 protein. More accurate definition of the se- 
cells is almost identical to that of 55.11. This hepatoma protein quence elements within the p55-R that are involved in 55.11 
lacks an N terminal portion (amino acids 1 297)corresponding binding, and those involved in the effects of TNF on nitric 
to that of 55.11 and also differs from 55.11 at the regions that oxide synthase and neutral sphingomyelinase, will help clarify 
correspond to residues 297 377 and residues 648 668 in 55.11. the role of the 55.11 protein in signaling. 
The searches of the data bank also revealed that proteins with The marked sequence similarity of the 55.11 protein with 
very high sequence homology to 55.11 exist in Saccharomyces SEN3, the yeast equivalent of the p112 protein, provides addi- 
cerevisiae (yeasts), Arabidopsis thaliana (plants) and Caen- tional clues to the function of the 55. l 1 protein. If, as does the 
orhabditis elegans (worms). In yeast, there are two known pro- p112 protein, the 55.11 protein occurs in the regulatory com- 
reins whose DNA sequences resemble that of 55.11 (the open plex of the 26S proteasome, than its binding to p55-R may 
reading frame YHR027c and SEN3; Fig. 4). The sizes of both modulate the proteolytic function of the proteasome, or con- 
are close to that of 55.11. YHR027c is known only by the versely, contribute to the degradation of the p55-R itself within 
sequencing of a genomic lone while SEN3 has been cloned as the proteasome. Of note, interferon 7, whose activities are 
a cDNA. The sites within 55.11 that are similar to those in closely related to those of TNF, has pronounced effects on the 
SEN3 correlate to the sites of its similarity to YHR027c, al- composition and function of the proteasomes [24,25]. Further- 
though much more similarity is evident between 55.11 and more, although there is no information regarding how the TNF 
YHR027c than between 55.11 and SEN3. The DNA sequence receptors are degraded, the rapidity with which TNF binding 
information available for the Arabidopsis thaliana and Caen- decreases after inhibition of protein synthesis, suggests that 
orhabditis elegans proteins, although only partial, clearly shows these molecules have a very short half-life, consistent with the 
(..._ 
Fig. 4. Comparison of the deduced amino acid sequence of human 55.11 to that of related proteins present in lower organisms. The sequences of
amino acids predicted for: the 55.11 cDNA; an open reading frame (YHR027c) within a cosmid erived from the 8th chromosome of Saccharomyces 
cerevisiae (nts 21253 24234, Accession Number U10399); SEN3, the cDNA of a Saccharomyces cerevisiae protein (Accession Number L06321); a 
partial cDNA of a protein of the plant Arabidopsis thaliana (Accession Number T21500); and a partial cDNA of a protein of the nematode 
Caenorhabditis elegans (Accession Number D27396). The 'KEKE' sequence in 55.11 is marked with a solid line and the sequence AYAGS(x)sLL 
with broken lines. The sequences were aligned using the PILEUP and PRETTYBOX programs of the GCG package. Gaps introduced to maximize 
alignments are denoted by dashes. 
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possibility that their degradation occurs in the proteasomes [5] Brakebusch, C., Nophar, Y., Kemper, O., Engelmann, H. and 
(unpublished data). Additional studies of the significance of the Wallach, D. (1992) EMBO J. 11,943-950. 
sequence similarity between the 55.11 protein and the pl12 [6] Tartaglia, L.A., Ayres, T.M., Wong, G.H. and Goeddel, D.V. 
(1993) Cell 74, 845-853. 
protein, and of the particular function of the p112 unit within [7] Itoh, N. and Nagata, S. (1993) J. Biol. Chem. 268, 10932 10937. 
the proteasome, will help clarify the functional significance of [8] Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, 
the 55.11 protein interaction with the p55-R. J.H. and Wallach, D. (1995) J. Biol. Chem. 270, 7795-7798. 
Although TNF itself has only been found in multicellular [9] Boldin, M.P., Mett, I.L., Varfolomeev, E.E., Chumakov, 1., 
Shemer-Avni, Y., Camonis, 3.H. and Wallach, D. (1995) J. Biol. 
organisms, the occurrence of proteins closely related to 55.11 Chem. 270, 387-391. 
in yeast, as well as in plants and nematodes, indicates that this [10] Wiegmann, K., Schutze, S., Machleidt, T., Witte, D. and Kronke, 
TNF-receptor associated protein serves an evolutionary con- M. (1994) Cell 78, 1005-1015. 
served function. This is not surprising since a number of known [11] Brakebusch, C., Nophar, Y., Kemper, O., Aderka, D., Engel- 
molecules and mechanisms regulated by TNF  seem to have mann, H. and Wallach, D. (1993) in: Tumor Necrosis-Factor: 
Molecular and Cellular Biology and Clinical Relevance, Vol. IV, 
appeared rather early in the evolutionary process. For example, pp. 40-51 (Fiers, W. and Buurman, W.A. Eds.) S. Karger, Basel. 
several protein kinases known to signal TNF  effects, as well as [12] Fields, S. and Song, O. (1989) Nature 340, 245-246. 
transcriptional factors affected by these kinases, also occur in [13] Kunkel, T.A. (1994) in: Current Protocols in Molecular Biology, 
yeast where they have important roles in signaling [21-23]. The pp. 8. l. 1-8.1.6 (Ausubel, F.M. et al. Eds.) Greene Publishing As- 
sociates, lnc and Wiley & Sons, Inc, New York. 
technical advantage of the genetic set up in yeast for studying [14] Smith, D.B. and Corcoran, L.M. (1994) in: Current Protocols in 
the function of an unknown protein, coupled with the advan- Molecular Biology, pp. 16.7.1-16.7.8 (Ausubel, F.M. et al. Eds.) 
tage of the cellular composition of nematodes for studying the Greene Publishing Associates, and Wiley and Sons, New York. 
role of an unknown protein in a multicellular organism, will [15] Frangioni, 3.V. and Neel, B.G. (1993) Anal. Biochem. 210, 179- 
187. 
facilitate lucidation of the function of the 55.11 protein. [16] Gossen, M. and Bujard, H. (1992) Proc. Natl. Acad. Sci. USA 89, 
5547 5551. 
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